Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11473 posts found.

Biotech grows up

December 4, 2003 Research and Development, Sales and Marketing alliances, biotech, partnerships, pharma

Sometimes it is hard to see where the fun lies in running a biotechnology company. Discounting the obvious success stories …
Feature

Making the most of medicines

November 26, 2003 Sales and Marketing NHS, healthcare, medicines management

Feature

Teva stretches lead in generics

November 5, 2003 Sales and Marketing

Teva has agreed to acquire US generics company Sicor for $3.4 billion and increased its third quarter profits 63%, led …
News

Making the switch

November 5, 2003 Sales and Marketing P, POM, switch

Switching is not a given and a successful POM to P transition requires considerable research and planning to extend unique …
Feature

GSK looks to consolidate UK lead with Avandamet

November 4, 2003 Sales and Marketing

News

Paxil patent blow for GSK

November 4, 2003 Sales and Marketing

News

Crestor goes head-to-head with Lipitor

November 4, 2003 Sales and Marketing

News

Generic threat to Lilly’s biggest seller

November 3, 2003 Sales and Marketing

A court challenge to Eli Lilly's patent on its number one drug Zyprexa could spell serious trouble for the company, …
News

Industry lukewarm on new labelling guidelines

October 31, 2003 Sales and Marketing

New guidelines on the labelling of medicines have received a cautious welcome from the pharma industry.The Government hopes the best …
News

GSK launches prostate drug

October 31, 2003 Sales and Marketing

GlaxoSmithKline is to launch Avodart, a new treatment for enlarged prostates, next week into a crowded $1.6 billion global market.The …
News

GSK in running for Pfizer incontinence drug

October 31, 2003 Sales and Marketing

GlaxoSmithKline has been tipped to buy a potential blockbuster incontinence drug from Pfizer ahead of the US company's merger with …
News

Look closer – The importance of local opinion leaders

October 29, 2003 Sales and Marketing key opinion leaders

There is no doubt that key opinion leader (KOL) development has always been a crucial component of the marketing mix; …
Feature

Limited lifting of NICE ‘ban’ on Tamiflu

October 29, 2003 Sales and Marketing

Roche have won a limited recommendation for its flu drug Tamiflu following a second NICE approval.An appraisal of flu drugs …
News

Betaferon and Avonex in head-to-head MS trial

October 29, 2003 Research and Development, Sales and Marketing

Schering AG is to launch the largest ever therapeutic multiple sclerosis trial, comparing its drug Betaferon with Biogen's rival Avonex.The …
News

AstraZeneca accused of blocking Losec competition

October 29, 2003 Sales and Marketing

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024